Description: Rituximab is a high-potency, genetically engineered chimeric monoclonal antibody that targets the CD20 antigen found on the surface of B-lymphocytes. By binding to these specific cells, it triggers the body's immune system to attack and eliminate them. It is supplied as a 500mg/50ml concentrate ($10\text{mg/ml}$) which must be diluted before being administered as an intravenous infusion.
In Nigeria, Rituximab is a critical specialized treatment used in oncology and rheumatology for managing various cancers and autoimmune disorders. Due to its complex handling requirements, it is available through premier clinical providers like Sanlive Pharmacy, ensuring cold-chain integrity ($2\text{°C}$ to $8\text{°C}$) and authentic sourcing for patient safety.
Important: This is a high-alert medication that must only be administered by trained healthcare professionals in a clinical setting equipped for resuscitation. It is NOT for self-administration. Patients must be screened for Hepatitis B and other chronic infections before starting treatment, as Rituximab can cause viral reactivation.
Rituximab 500mg/50ml is primarily used to treat:
Non-Hodgkin’s Lymphoma (NHL): Including follicular lymphoma and diffuse large B-cell lymphoma
Chronic Lymphocytic Leukemia (CLL): Often used in combination with chemotherapy
Rheumatoid Arthritis: For adult patients who have not responded well to other TNF-antagonist therapies
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA): Severe vascular inflammatory conditions
Pemphigus Vulgaris: A rare autoimmune disease causing severe skin blistering
This product is suitable for:
Patients with specific B-cell malignancies confirmed by diagnostic testing
Individuals with severe autoimmune conditions that are refractory to standard treatments
Patients who have been cleared of active infections (especially Hepatitis B and Tuberculosis)
Not recommended for: Individuals with a severe, active infection or a severely weakened immune system. It is contraindicated in patients with a known hypersensitivity to rituximab or murine (mouse) proteins. Use in pregnancy is generally avoided unless the benefit to the mother outweighs the potential risk to the fetus.
Clinical Setting Only: Must be administered in a hospital or specialized infusion center
Pre-medication: Patients are typically given an antipyretic (e.g., Paracetamol) and an antihistamine (e.g., Chlorphenamine) before each infusion to reduce the risk of infusion-related reactions
Slow Infusion: The first dose is started at a very slow rate; the speed may be increased gradually if the patient tolerates the treatment well
Dilution: The 50ml concentrate must be diluted in an infusion bag of $0.9\%$ Sodium Chloride or $5\%$ Dextrose to a calculated concentration as per the doctor's prescription
Monitoring: Vital signs (blood pressure, heart rate, and temperature) are monitored closely throughout the procedure
Rituximab can cause significant side effects, particularly during the first infusion:
Infusion-Related Reactions: Fever, chills, shivering, itching, and rash (most common within the first 2 hours)
Infections: Increased susceptibility to bacterial, viral, or fungal infections due to B-cell depletion
Blood Disorders: Temporary reduction in white blood cells (neutropenia) or platelets
General: Fatigue, headache, and nausea
Serious: Progressive Multifocal Leukoencephalopathy (PML)—a very rare but serious brain infection—and severe skin reactions (Stevens-Johnson Syndrome)
Roche (MabThera), Sandoz (Rixathon), or Celltrion (Truxima) – Available as both the innovator brand and high-quality biosimilars, all requiring strict temperature-controlled storage.
Cold-Chain Guaranteed: We maintain a strict $2\text{°C}$ to $8\text{°C}$ environment from the manufacturer to the point of delivery
Verified Authenticity: 100% genuine specialized biologics sourced from authorized global distributors
Expert Support: Our clinical pharmacists provide detailed drug interaction checks and coordination with your oncology team
Secure Logistics: Insured and specialized transport to hospitals across Lagos, Abuja, and all regions of Nigeria
How long does the infusion take?
The first infusion usually takes 4 to 6 hours to ensure safety. Subsequent infusions can often be administered faster (around 2 to 3 hours) if the initial dose was well-tolerated.
Why do I need a Hepatitis B test first?
Rituximab targets B-cells, which are part of your immune memory. If you have ever had Hepatitis B, the virus could "wake up" (reactivate) while your immune system is suppressed, leading to severe liver damage.
Can I get vaccinated while on Rituximab?
You should avoid "live" vaccines during treatment. Because Rituximab clears B-cells, other vaccines (like the flu shot) may not work as effectively. Discuss your vaccination schedule with your specialist before starting therapy.
Where can I buy authentic Rituximab 500mg/50ml in Nigeria?
You can fulfill your specialist's prescription for Rituximab (MabThera/Rixathon) at Sanlive Pharmacy & Stores for guaranteed cold-chain integrity and professional clinical care.
No reviews yet.
Login to write a review.
Related Products